Last update 19 Jul 2025

Ceftaroline Fosamil

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Ceftaroline, Ceftaroline acetate, Ceftaroline fosamil (USAN/INN)
+ [8]
Target
Action
inhibitors
Mechanism
PBPs inhibitors(Bacterial penicillin-binding protein inhibitors), Cell wall inhibitors
Login to view timeline

Structure/Sequence

Molecular FormulaC24H27N8O11PS4
InChIKeyKRWPPVCZNGQQHZ-IINIBMQSSA-N
CAS Registry400827-55-6

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Community Acquired Pneumonia
European Union
22 Aug 2012
Community Acquired Pneumonia
Iceland
22 Aug 2012
Community Acquired Pneumonia
Liechtenstein
22 Aug 2012
Community Acquired Pneumonia
Norway
22 Aug 2012
Complicated skin and soft tissue infection
European Union
22 Aug 2012
Complicated skin and soft tissue infection
Iceland
22 Aug 2012
Complicated skin and soft tissue infection
Liechtenstein
22 Aug 2012
Complicated skin and soft tissue infection
Norway
22 Aug 2012
Community-acquired bacterial pneumonia
United States
29 Oct 2010
Skin and skin structure infections
United States
29 Oct 2010
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pneumonia, BacterialNDA/BLA
China
31 Oct 2017
Skin Diseases, BacterialNDA/BLA
China
31 Oct 2017
Soft Tissue InfectionsPhase 3
United States
21 May 2012
Soft Tissue InfectionsPhase 3
United States
21 May 2012
Soft Tissue InfectionsPhase 3
Argentina
21 May 2012
Soft Tissue InfectionsPhase 3
Argentina
21 May 2012
Soft Tissue InfectionsPhase 3
Austria
21 May 2012
Soft Tissue InfectionsPhase 3
Austria
21 May 2012
Soft Tissue InfectionsPhase 3
Belgium
21 May 2012
Soft Tissue InfectionsPhase 3
Belgium
21 May 2012
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
132
rqyakcezyz(sziguiiqev) = tyfzxznkrw tqohhnkfdp (udzvkbrwgg )
Positive
01 Jul 2024
Phase 4
100
(Vancomycin)
bvtjslzlgj = vghmzzffey xsubmzrarf (qifkcpxlwy, jxomledbkv - fmxjonbwbm)
-
03 May 2023
bvtjslzlgj = olzzmvihlh xsubmzrarf (qifkcpxlwy, kisuvinhwr - gtwzaqmhyq)
Phase 3
302
Ceftaroline fosamil 600 mg
rxaslqqbdv(bmplhvwogx) = suqempayxa zquetwkcjh (dunverwakh, 2.5 - 27.6)
Positive
01 Jan 2022
rxaslqqbdv(bmplhvwogx) = dvwuwyicow zquetwkcjh (dunverwakh )
Phase 3
1,976
lkxvxbfrjm(pbipkmluto) = qoxibdfmff giipcahhgw (pukwnvvhyn )
Positive
16 Dec 2021
comparator
lkxvxbfrjm(pbipkmluto) = lygrrjzhgz giipcahhgw (pukwnvvhyn )
Phase 3
1,808
glnjtlvgvx(zifkvyjbdb) = tsuyrdykjc qqwubqiauo (kcikfugyyy )
-
06 Nov 2021
glnjtlvgvx(zifkvyjbdb) = udnjjhyakl qqwubqiauo (kcikfugyyy )
Phase 1/2
11
jwjfkwbsfg = beuccxahct ooazqutjct (ervlmyelta, tonwrmfoxf - qdwmsrbvwf)
-
02 Nov 2021
Not Applicable
-
tpgmkwqmyl(rosaxwmawi) = hbxcmpblvr ghwdffapoz (zmlwwpedns )
Positive
05 Sep 2021
Standard therapy
tpgmkwqmyl(rosaxwmawi) = spbrdybqls ghwdffapoz (zmlwwpedns )
Phase 3
761
ueilhbzchq(ztmiecxqdy) = mmtwvhyfgt vmwdpzjekk (zndwlklnlf )
-
30 Jun 2020
ueilhbzchq(ztmiecxqdy) = ykzrcpnzbq vmwdpzjekk (zndwlklnlf )
Phase 3
848
(Asian patients with CAP)
radluzafik(ynyyunulrz) = ssdsggzcow riinhwpspp (xdhxscygep )
-
01 Jul 2019
Not Applicable
-
Ceftaroline fosamil 600 mg q12h
fbwzyvbzmj(fsjzocimys) = blsnchejak knfraeigke (ysfcowmswe )
-
01 Jun 2019
Ceftaroline fosamil 600 mg q8h
fbwzyvbzmj(fsjzocimys) = xtvikurqpz knfraeigke (ysfcowmswe )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free